Translational Psychiatry
Hierarchical multiclassification of Alzheimer’s disease based on DIABLO fusion of multimodal neuroimaging and clinical information
By Jing Cui, Yuxiu Mou, Huibin Xiao and 3 others.
Abstract
Abstract Current approaches relying on structural magnetic resonance imaging (sMRI) and functional magnetic resonance imaging (fMRI) often employ simple data concatenation or decision-level fusion, which overlooks deeper intermodal relationships. Moreover, most classification models do not reflect clinically established diagnostic pathways. To address these limitations, we introduce a feature-level fusion framework based on multiblock partial least squares discriminant analysis (DIABLO), combined with hierarchical multi-class modeling, to leverage multimodal synergies for improved classification of clinically-diagnosed AD. This study integrates sMRI, fMRI, and clinical information from the ADNI dataset (872 participants: 443 NC, 300 MCI, 129 AD). Feature fusion was performed using kernel principal component analysis (KPCA) and DIABLO, respectively. A hierarchical multi-classification model was constructed and validated under three diagnostic scenarios (NC → MCI → AD, MCI → NC → AD, AD → NC → MCI). We compared seven classifiers (SVM, RF, GBDT, XGBoost, AdaBoost, Bagging, Stacking) based on KPCA fusion. Ablation experiments confirmed the synergistic value of multimodal integration: three-modal DIABLO achieved an AUC of 0.934 for NC vs. MCI, substantially outperforming single-modal fMRI (AUC 0.797). The DIABLO-based model using sMRI, fMRI, and clinical information achieved AUCs of 0.992 for AD vs. non-AD and 0.934 for NC vs. MCI, outperforming KPCA-based fusion. This study demonstrates that fusing sMRI, fMRI, and clinical information provides complementary biological features, improving multi-classification accuracy across the AD spectrum. DIABLO appears to be a powerful and interpretable multimodal fusion framework, showing great potential for auxiliary AD diagnosis and warranting further validation in larger and more diverse cohorts.



